ERBB2 and ovarian carcinoma: Triggering apoptosis of ovarian cancer cells by trastuzumab, anti-HER-2 biosimilars, and AVEC was tested by quantifying phosphatidylserine externalization detected in flow cytometry and fluorescence microscopy.